Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.

Toombs J, Foiani MS, Paterson RW, Heslegrave A, Wray S, Schott JM, Fox NC, Lunn MP, Blennow K, Zetterberg H.

J Alzheimers Dis. 2017;56(3):885-891. doi: 10.3233/JAD-161126.

PMID:
28059797
2.

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.

Paterson RW, Heywood WE, Heslegrave AJ, Magdalinou NK, Andreasson U, Sirka E, Bliss E, Slattery CF, Toombs J, Svensson J, Johansson P, Fox NC, Zetterberg H, Mills K, Schott JM.

Transl Psychiatry. 2016 Nov 15;6(11):e952. doi: 10.1038/tp.2016.194.

3.

Music Perception in Dementia.

Golden HL, Clark CN, Nicholas JM, Cohen MH, Slattery CF, Paterson RW, Foulkes AJ, Schott JM, Mummery CJ, Crutch SJ, Warren JD.

J Alzheimers Dis. 2017;55(3):933-949.

4.

Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?

Weston PS, Paterson RW, Dickson J, Barnes A, Bomanji JB, Kayani I, Lunn MP, Mummery CJ, Warren JD, Rossor MN, Fox NC, Zetterberg H, Schott JM.

J Alzheimers Dis. 2016 Oct 18;54(4):1297-1302.

5.

Effect of age at onset on cortical thickness and cognition in posterior cortical atrophy.

Suárez-González A, Lehmann M, Shakespeare TJ, Yong KX, Paterson RW, Slattery CF, Foulkes AJ, Rabinovici GD, Gil-Néciga E, Roldán-Lora F, Schott JM, Fox NC, Crutch SJ.

Neurobiol Aging. 2016 Aug;44:108-13. doi: 10.1016/j.neurobiolaging.2016.04.012. Epub 2016 Apr 25.

6.

Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?

Paterson RW, Toombs J, Chapman MD, Nicholas JM, Heslegrave AJ, Slattery CF, Foulkes AJ, Clark CN, Lane CA, Weston PS, Lunn MP, Fox NC, Zetterberg H, Schott JM.

Alzheimers Dement (Amst). 2015 Jul 2;1(3):380-4. doi: 10.1016/j.dadm.2015.06.003. eCollection 2015 Sep.

7.

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.

Paterson RW, Abdi Z, Haines A, Schott JM.

Clin Neurol Neurosurg. 2016 May;144:64-6. doi: 10.1016/j.clineuro.2016.02.036. Epub 2016 Mar 3. No abstract available.

PMID:
26989943
8.

Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.

Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, Carecchio M, Reid E, Heslegrave A, Fenoglio C, Scarpini E, Schott JM, Fox NC, Hardy J, Bhatia KP, Heales S, Sebire NJ, Zetterberg H, Mills K.

Mol Neurodegener. 2016 Feb 23;11:20. doi: 10.1186/s13024-016-0086-3. No abstract available.

9.

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.

Weston PS, Paterson RW, Modat M, Burgos N, Cardoso MJ, Magdalinou N, Lehmann M, Dickson JC, Barnes A, Bomanji JB, Kayani I, Cash DM, Ourselin S, Toombs J, Lunn MP, Mummery CJ, Warren JD, Rossor MN, Fox NC, Zetterberg H, Schott JM.

Alzheimers Dement (Amst). 2015 Nov 2;1(4):440-446. eCollection 2015 Dec.

10.

Increased CSF neurogranin concentration is specific to Alzheimer disease.

Wellington H, Paterson RW, Portelius E, Törnqvist U, Magdalinou N, Fox NC, Blennow K, Schott JM, Zetterberg H.

Neurology. 2016 Mar 1;86(9):829-35. doi: 10.1212/WNL.0000000000002423. Epub 2016 Jan 29.

11.

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.

Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, Carecchio M, Reid E, Heslegrave A, Fenoglio C, Scarpini E, Schott JM, Fox NC, Hardy J, Bhatia K, Heales S, Sebire NJ, Zetterberg H, Mills K.

Mol Neurodegener. 2015 Dec 1;10:64. doi: 10.1186/s13024-015-0059-y. Erratum in: Mol Neurodegener. 2016;11:20. Bahtia, Kailash and Zetterburg, Henrik [Corrected to Bhatia, Kailash and Zetterberg, Henrik].

12.

Pain and temperature processing in dementia: a clinical and neuroanatomical analysis.

Fletcher PD, Downey LE, Golden HL, Clark CN, Slattery CF, Paterson RW, Rohrer JD, Schott JM, Rossor MN, Warren JD.

Brain. 2015 Nov;138(Pt 11):3360-72. doi: 10.1093/brain/awv276. Epub 2015 Oct 12.

13.

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.

Paterson RW, Toombs J, Slattery CF, Nicholas JM, Andreasson U, Magdalinou NK, Blennow K, Warren JD, Mummery CJ, Rossor MN, Lunn MP, Crutch SJ, Fox NC, Zetterberg H, Schott JM.

J Neurol. 2015 Dec;262(12):2722-30. doi: 10.1007/s00415-015-7904-3. Epub 2015 Sep 26.

PMID:
26410752
14.

The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid.

Toombs J, Paterson RW, Nicholas JM, Petzold A, Schott JM, Zetterberg H.

Clin Chem Lab Med. 2015 Nov;53(12):e329-32. doi: 10.1515/cclm-2015-0414. No abstract available.

PMID:
26103629
15.

Auditory hedonic phenotypes in dementia: A behavioural and neuroanatomical analysis.

Fletcher PD, Downey LE, Golden HL, Clark CN, Slattery CF, Paterson RW, Schott JM, Rohrer JD, Rossor MN, Warren JD.

Cortex. 2015 Jun;67:95-105. doi: 10.1016/j.cortex.2015.03.021. Epub 2015 Apr 8.

16.

Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy.

Shakespeare TJ, Kaski D, Yong KX, Paterson RW, Slattery CF, Ryan NS, Schott JM, Crutch SJ.

Brain. 2015 Jul;138(Pt 7):1976-91. doi: 10.1093/brain/awv103. Epub 2015 Apr 19.

17.

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.

Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H.

J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1240-7. doi: 10.1136/jnnp-2014-309562. Epub 2015 Jan 14.

18.

Biomarkers in dementia: clinical utility and new directions.

Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O'Brien JT, Fox NC, Halliday GM, Schott JM.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1426-34. doi: 10.1136/jnnp-2014-307662. Epub 2014 Sep 26. Review.

19.

Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.

Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, Cox AL, Lennox B, Stamelou M, Bhatia KP, Schott JM, Coles AJ, Kullmann DM, Vincent A.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):708-13. doi: 10.1136/jnnp-2014-308736. Epub 2014 Sep 22.

PMID:
25246644
20.

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Paterson RW, Bartlett JW, Blennow K, Fox NC; Alzheimer's Disease Neuroimaging Initiative., Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM.

Transl Psychiatry. 2014 Jul 29;4:e419. doi: 10.1038/tp.2014.58.

Supplemental Content

Loading ...
Support Center